New hope for leukemia patients: targeted drugs enter major trial
NCT ID NCT07203352
Summary
This study is testing whether adding new targeted drugs to standard chemotherapy works better than chemotherapy alone for adults newly diagnosed with a fast-growing blood cancer called acute T-lymphocytic leukemia. About 154 patients will be randomly assigned to receive either the new combination or standard treatment. The main goal is to see if the new approach helps patients live longer and keeps the cancer from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Hematology,Nanfang Hospital, Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.